YI - MCAP CO - 111, Inc.

The 111, Inc. (YI) digital ecosystem automates medication dispensing and remote physician consultations via robotic logistics centers. The business leverages its status as a leading Chinese B2B marketplace, integrating cloud accounting into retail operations. The price trajectory of the asset, which has a capitalization of 0.02, highlights growth driven by online distribution, while the market value already prices in the competitive pressure on profitability.

Investors seek a balance between asset quality and market value. This indicator measures the aggregate capital of all shares, determining whether a company meets the indexing criteria for large funds. For 111, Inc. (YI), this figure reflects market confidence in the scale of B2B supply digitalization via Drug Mall. Logistics efficiency directly impacts the liquidity of the securities. The price action of the company's stock market valuation visualizes the risks of forced sell-offs.